Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-01-20

Clinical Trial Update: IL-7 Receptor Polymorphisms and Immune Recovery With HAART

View source ↗

Summary

A completed study assessing whether IL-7 receptor polymorphisms influence immune recovery in HIV-infected patients treated with HAART.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: The Alfred | Conditions: HIV Infections | Status: COMPLETED